Function
16 FDA-allowed Structure/Function Claims
Helps maintain healthy joints
Improves joint flexibility and mobility
Promotes joint health within 7 days
Supports healthy inflammatory response during physical activity
Provides a herbal approach for post-exercise pain relief.
CLINICAL STUDY OF JointAlive?
A180-day open-label human clinical study was conducted to prove the efficacy and safety of JointAlive?
Condition :prove the efficacy and safety of JointAlive.
Dose :600 mg/day
Participants :aged between 55 and 80 years old with knee osteoarthritis were enrolled.
Outcome :JointAlive? relieved joint discomfort as quickly as 7 days.
85 of subjects feel significant joint health improvement at the end of the study, compared to the baseline.

Why choose Joint Alive?
Human Clinical Trials Pre-clinical Studies
Mechanism of Action Study Peer-Reviewed Publications
Safety Studies 5 Patents
NDIN#1172 Structure/Function Claims without FDA Objection
Specification
Product | Joint Alive |
Test Item | Test Result |
Moisture % | 4.85 |
Ash g/100 g | 2.36 |
Dioscin % | 5.68 |
Icariin % | 2.44 |
Tanshinone IIA % | 0.218 |
Particle Size (80 mesh, through) % | 98.8 |
Arsenic (As) mg/kg | 0.133 |
Lead (Pb) mg/kg | 0.123 |
Cadmium (Cd) mg/kg | 0.0375 |
Mercury (Hg) mg/kg | Not Detected (<0.01) |